跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 22 天前AI 评分32

Genmab 因癌症数据股价上涨,Iovance、Coherus 下跌

Genmab's stock rises on cancer data, while Iovance, Coherus tumble

AI 导读

Genmab 因癌症数据股价上涨,Iovance、Coherus 股价下跌。过去24小时,癌症试验消息推动多只股票双向波动,原文称将汇总关键结果,但全文需订阅阅读。

正文

Can­cer tri­al news drove a num­ber of stock moves in both di­rec­tions over the past 24 hours. Here’s a sum­ma­ry of key re­sults and their …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news